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PCardiac Ankyrin Repeat Protein Gene
(ANKRD1) Mutations in Hypertrophic Cardiomyopathy
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Objectives The purpose of this study was to explore a novel disease gene for hypertrophic cardiomyopathy (HCM) and to
evaluate functional alterations caused by mutations.
Background Mutations in genes encoding myofilaments or Z-disc proteins of the cardiac sarcomere cause HCM, but the
disease-causing mutations can be found in one-half of the patients, indicating that novel HCM-susceptibility
genes await discovery. We studied a candidate gene, ankyrin repeat domain 1 (ANKRD1), encoding for the car-
diac ankyrin repeat protein (CARP) that is a Z-disc component interacting with N2A domain of titin/connectin
and N-terminal domain of myopalladin.
Methods We analyzed 384 HCM patients for mutations in ANKRD1 and in the N2A domain of titin/connectin gene (TTN).
Interaction of CARP with titin/connectin or myopalladin was investigated using coimmunoprecipitation assay to
demonstrate the functional alteration caused by ANKRD1 or TTN mutations. Functional abnormalities caused by
the ANKRD1 mutations were also examined at the cellular level in neonatal rat cardiomyocytes.
Results Three ANKRD1missense mutations, Pro52Ala, Thr123Met, and Ile280Val, were found in 3 patients. All mutations
increased binding of CARP to both titin/connectin and myopalladin. In addition, TTNmutations, Arg8500His, and
Arg8604Gln in the N2A domain were found in 2 patients, and these mutations increased binding of titin/connectin to
CARP. Myc-tagged CARP showed that the mutations resulted in abnormal localization of CARP in cardiomyocytes.
Conclusions CARP abnormalities may be involved in the pathogenesis of HCM. (J Am Coll Cardiol 2009;54:334–42)
© 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.12.082a
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(ardiomyopathy is a primary heart muscle disorder caused
y functional abnormalities of cardiomyocytes. There are
everal clinical subtypes of cardiomyopathy, and the most
revalent subtype is hypertrophic cardiomyopathy (HCM)
1,2). HCM is characterized by hypertrophy and diastolic
ysfunction of cardiac ventricles accompanied by cardio-
yocyte hypertrophy, fibrosis, and myofibrillar disarray
1). Although the etiologies of HCM have not been fully
lucidated, 50% to 70% of the patients with HCM have
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edical and Dental University, Tokyo, Japan. This work was supported in part by 2pparent family histories consistent with autosomal dom-
nant genetic trait (3), and recent genetic analyses have
evealed that a significant percentage of HCM is caused
See page 343
y mutations in the genes encoding for myofilaments and
-disc proteins of the cardiac sarcomere, with the ma-
ority of mutations identified in MYH7-encoded beta
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July 21, 2009:334–42 CARP (ANKRD1) Mutations in HCMyosin heavy chain and MYBPC3-encoded myosin-
inding protein C (3).
Ankyrin repeat domain 1 (ANKRD1)-encoded cardiac
driamycin responsive protein (4), or cardiac ankyrin repeat
rotein (CARP) (5), is a transcription cofactor and an early
ifferentiation marker of cardiac myogenesis, expressed in
he heart during embryonic and fetal development. CARP
xpression is up-regulated in the adult heart at end-stage
eart failure (6). In addition, increased CARP expression
as found in hypertrophied hearts from experimental mu-
ine models (7,8). These observations suggest a pivotal role
or CARP in cardiac muscle function in both physiological
nd pathological conditions. Although CARP is known to
e involved in the regulation of gene expression in the heart,
ang et al. (9) demonstrated that CARP located to both the
arcoplasm and nucleus, suggesting a shuttling of CARP in
ellular components. Within the I-band region of sarco-
ere, CARP bound to both the N2A domain of titin/
onnectin encoded by titin/connectin gene (TTN) and the
-terminal domain of myopalladin encoded by MYPN.
ence, titin/connectin and myopalladin function in part as
nchoring proteins of “sarcomeric CARP” (9,10).
Titin/connectin is the most giant protein expressed in the
triated muscles, which is involved in sarcomere assembly,
orce transmission at the Z-disc, and maintenance of resting
ension in the I-band region (11,12). In cardiac muscle,
here are 2 titin isoforms, N2B and N2BA. The N2B
soform contains a cardiac specific N2B domain, and the
2BA isoform contains both N2B and N2A domains. Both
2A and N2B domains, within the extensible I-band
egion, function as a molecular spring that develops passive
ension; the expression of N2B isoform results in a higher
assive stiffness than that of N2AB isoform. We previously
eported an HCM-associated mutation localizing to the
2B domain (13), and Gerull et al. (14) reported other
TN mutations in the Z/I transition domain. These obser-
ations suggest that the I-band region of titin/connectin
ontains elastic components extending with stretch to gen-
rate passive force, which plays an important role in the
aintenance of cardiac function.
Another protein that anchors CARP at the Z/I band is
yopalladin, a cytoskeletal protein containing 3 proline-
ich motifs and 5 Ig domains. The proline-rich motifs in the
entral part is required for binding to nebulin/nebulette, and
he Ig domains at the N-terminus and C-terminus are
nvolved in the binding to CARP and sarcomeric a-actinin,
espectively (9). It has been suggested that myopalladin
layed key roles in sarcomere/Z-disc assembly, myofibrillo-
enesis, recruitment of the other Z/I-band elements, and
ignaling in the Z/I-band (9).
In this study, we analyzed unrelated patients with here-
ofore genotype-negative HCM for mutations in ANKRD1
nd found 3 mutations that showed abnormal binding to
yopalladin and titin/connectin. In addition, we searched
or mutations in the reciprocal CARP-binding N2A do-
ain of titin/connectin and identified 2 HCM-associated mutations in TTN causing ab-
ormal binding to CARP. We
eport here that abnormal CARP
ssembly in the cardiac muscles
ay be involved in the pathogen-
sis of HCM.
ethods
ubjects. A total of 384 unre-
ated patients with HCM were
ncluded in this study. The pa-
ients were diagnosed based on
edical history, physical exami-
ation, 12-lead electrocardiogram,
chocardiography, and other spe-
ial tests if necessary. The diagnos-
ic criteria for HCM included left
entricular wall thickness 13
m on echocardiography, in the
bsence of coronary artery disease,
yocarditis, and hypertension.
he patients had been analyzed previously for mutations in
reviously published myofilament- and Z-disc associated
enes, and no mutation was found in any of the known
CM-susceptibility genes (15–18). Ethnically-matched
ealthy persons (400 from Japan, and 300 from the U.S.) were
sed as controls. Blood samples were obtained from the
ubjects after given informed consent. The protocol for re-
earch was approved by the Ethics Reviewing Committee of
edical Research Institute, Tokyo Medical and Dental Uni-
ersity (Japan) and by the Mayo Foundation Institutional
eview Board (U.S.).
utational analysis. Using intronic primers, each trans-
ated ANKRD1 exon was amplified by polymerase chain
eaction (PCR) from genomic DNA samples. TTN exons
9 to 104 corresponding to the N2A domain including
inding domains to CARP and p94/calpain were amplified
y PCR in exon-by-exon manner. Sequence of primers and
CR conditions used in this study are available upon
equest. PCR products were analyzed by direct sequencing
r by denaturing high-performance liquid chromatography
ollowed by sequencing analysis. Sequencing was performed
sing Big Dye Terminator chemistry (version 3.1, Applied
iosystems, Foster City, California) and ABI3100 DNA
nalyzer (Applied Biosystems).
oimmunoprecipitation (co-IP) assay. We obtained
omplementary deoxyribonucleic acid (cDNA) fragments of
uman ANKRD1 and TTN by reverse-transcriptase PCR
rom adult heart messenger ribonucleic acid. A wild-type
WT) full-length CARP cDNA fragment spanned from
p249 to bp1208 of GenBank Accession No. NM_014391
corresponding to aa1-aa319). Three equivalent mutant
DNA fragments containing C to G (Pro52Ala mutation),
to T (Thr123Met mutation), or A to G (Ile280Val
Abbreviations
and Acronyms
Ab  antibody
ANKRD1  ankyrin repeat
domain 1
CARP  cardiac ankyrin
repeat protein
cDNA  complementary
deoxyribonucleic acid
Co-IP 
coimmunoprecipitation
DAPI  4=6-diamidino-2-
phenylindole
DCM  dilated
cardiomyopathy
HCM  hypertrophic
cardiomyopathy
PCR  polymerase chain
reaction
WT  wild typeutation) substitutions were obtained by the primer-
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CARP (ANKRD1) Mutations in HCM July 21, 2009:334–42irected mutagenesis method. A WT TTN cDNA frag-
ent encoding N2A domains (from bp25535 to bp26465
f NM_133378 corresponding to aa8437-aa8747) was
btained, and 3 TTN mutants carrying T to C (non–
isease-associated Ile8474Thr polymorphism), G to A
HCM-associated Arg8500His mutation), or G to A
HCM-associated Arg8604Gln mutation) substitutions
ere created by the primer-mediated mutagenesis method.
he cDNA fragments of ANKRD1 were cloned into
yc-tagged pCMV-Tag3 (Stratagene, La Jolla, California),
nd TTN and MYPN cDNA fragments were cloned into
EGFP-C1 (Clontech, Mountain View, California). These
onstructs were sequenced to ensure that no errors were
ntroduced.
Cellular transfection and protein extractions were per-
ormed as described previously (19), and co-IP assays were
erformed using the Catch and Release version 2.0 Revers-
ble Immunoprecipitation System according to the manu-
acturer’s instructions (Millipore, Billerica, Massachusetts).
mmunoprecipitates were separated on sodium dodecyl
ulfate–polyacrylamide gel electrophoresis gels and trans-
erred to a nitrocellulose membrane. After a pre-incubation
ith 3% skim milk in phosphate-buffered saline, the mem-
rane was incubated with primary rabbit anti-myc poly-
lonal antibody (Ab) or mouse anti-GFP monoclonal
ntibody Ab (1:100, Santa Cruz Biotechnology, Santa
ruz, California), and with secondary goat anti-rabbit
for polyclonal Ab) or rabbit anti-mouse (for monoclonal
b) IgG HRP-conjugated Ab (1:2,000, Dako A/S,
rostrup, Denmark). Signals were visualized by Immo-
ilon Western Chemiluminescent HRP Substrate (Mil-
ipore) and Luminescent Image Analyzer LAS-3000 mini
Fujifilm, Tokyo, Japan), and their densities were quan-
ified by using Multi Gauge version 3.0 (Fujifilm, Tokyo,
apan). Numerical data were expressed as mean  SEM.
tatistical differences were analyzed using 1-way analysis
f variance and the Student t test for paired values.
eans were compared by independent sample t tests
ithout correction for multiple comparisons. A p value
0.05 was considered to be statistically significant.
ndirect immunofluorescence microscopy. All care and
reatment of animals were in accordance with “Guidelines for
he Care and Use of Laboratory Animals” published by the
ational Institutes of Health (NIH Publication 85-23, revised
985) and subjected to prior approval by the local animal
rotection authority. Neonatal rat cardiomyocytes were pre-
ared as described previously (19). Eighteen hours and 48 h
fter the transfection, cardiomyocytes were washed with
hosphate-buffered saline, fixed for 15 min in 100% ethanol at
20°C. Transfected cells were incubated in blocking solution,
nd stained by primary rabbit anti-myc polyclonal Ab (1:100,
anta Cruz Biotechnology) and mouse anti–-actinin mono-
lonal Ab (1:800, Sigma-Aldrich, St. Louis, Missouri), fol-
owed by secondary sheep anti-rabbit IgG FITC-conjugated
b (1:500, Chemicon, Boronia, Victoria, Australia) and Alexa
uor 568 goat anti-mouse IgG (1:500, Molecular Probes, dugeue, Oregon). All cells were mounted on cover-glass using
owiol 4-88 Reagent (Calbiochem, Darmstadt, Germany)
ith 4=6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich),
nd images from at least 200 transfected cells were analyzed
ith an LSM510 laser-scanning microscope (Carl Zeiss Mi-
roscopy, Jena, Germany).
esults
dentification of ANKRD1 (CARP) and TTN mutations
n HCM. Eleven distinct sequence variations in ANKRD1
ere identified among the 384 patients with HCM (Fig. 1A).
our intronic variants, 2 nonsynonymous substitutions, and
synonymous variation were polymorphisms, because they
ere also found in the controls. A nonsense mutation
c.423CT in exon 2 yielding Gln59ter) was found in 2
atients with familial HCM and was absent in the controls,
ut was not cosegregated with the disease in both families,
uggesting that they were not associated with HCM. In
ontrast, 3 missense mutations, Pro52Ala (c.402CG in
xon 2), Thr123Met (c.616CT in exon 4), and Ile280Val
c.1086AG in exon 8), identified in 3 unrelated HCM
atients, were not found in the controls.
Sequence variations in TTN at the N2A domain contain-
ng binding region to CARP and p94/calpain were searched
or in the patients, and 8 variations were identified (Fig.
B). An intronic variation and 3 synonymous variations
ere polymorphisms observed in the controls. Two nonsyn-
nymous variations, Ile8474Thr (c.25645TC in exon 99)
nd Asp8672Val (c.26239AT in exon 102), were not
ssociated with HCM, because Ile8474Thr was found in
he controls and Asp8672Val did not cosegregate with the
isease in a multiplex family. On the other hand, 2 missense
utations, Arg8500His (c.25723GA in exon 99) and
rg8604Gln (c.26035GA in exon 100), identified in
amilial HCM patients, were not found in the controls.
linical phenotypes. Clinical findings of the patients car-
ying the ANKRD1 or TTN mutations are summarized in
able 1. All patients manifested with HCM except
M1288 II-2, who had mild cardiac hypertrophy. Her
ather had died suddenly of unknown etiology at the age of
0 years. Two unaffected brothers of the patient did not
arbor the mutation (Fig. 1C). The proband patient with
he TTN Arg8606Gln mutation (CM1480) (Table 1)
howed asymmetric septum hypertrophy. A family study
evealed that his father had unexplained sudden cardiac
eath. His son (CM1481) (Table 1) was affected and carried
he same mutation (Fig. 1D).
ltered interaction between titin/connectin and CARP
aused by the TTN or CARP mutations. To investigate
he functional alterations caused by the CARP mutations in
he binding to titin/connectin N2A domain, WT-, Pro52Ala-,
hr123Met-, or Ile280Val-CARP construct was cotransfected
ith the WT TTN-N2A construct into COS-7 cells. Western
lot analyses of immunoprecipitates from the transfected cells
emonstrated that HCM-associated CARP mutations signif-
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July 21, 2009:334–42 CARP (ANKRD1) Mutations in HCMcantly increased binding to TTN-N2A (2.22 0.76 arbitrary
nits [AU], p 0.05; 1.98 0.52 AU, p 0.01; 2.16 0.64
U, p 0.05, respectively) (Figs. 2A and 2B). Reciprocally, the
ffect of titin/connectin mutations in binding to CARP was
ssessed. The TTN-N2A constructs, WT-, HCM-associated
utants (Arg8500His- and Arg8604Gln-TTN), or non–
isease-related variant (Ile8474Thr) TTN-N2A were cotrans-
ected with WT CARP. Western blot analyses showed that
Figure 1 Mutational Analyses of ANKRD1 and TTN in HCM
(A) Sequence variations found in ANKRD1. Single-letter code was used to indicate
exons 1 to 9. Dotted boxes indicate ankyrin repeat domains encoded by exons 5
sponding to exons 98, 99, and 102 to 104. Dotted boxes indicate tyrosine-rich m
families with (C) the ANKRD1 T123M (CM 1288 family) and (D) the TTN R8604Q
patients, respectively. Open squares and circles represent unaffected or unexamin
patient. Presence () or absence () of the mutations is noted.rg8500His and Arg8604Gln significantly increased the bind- mng to CARP (2.78  0.40 AU or 3.16  0.40 AU,
espectively, p  0.001 in each case) (Figs. 2A and 2B),
hereas the non–disease-related variant (Ile8474Thr) did not
lter the binding (1.18 0.11 AU), despite equal expression of
roteins.
ltered interaction between myopalladin and CARP
aused by the CARP mutations. Because CARP bound
lso to myopalladin, we investigated the effects of CARP
mino acid residue. Solid boxes represent protein coding region corresponding to
B) Sequence variations found in TTN. Solid boxes represent Ig domains corre-
coded by exons 99 to 101. Pedigrees of hypertrophic cardiomyopathy (HCM)
480 family). Filled squares and circles indicate affected male and female
le and female patients with HCM, respectively. An arrow indicates the probandthe a
to 8. (
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ed mautations in binding to myopalladin. The WT or mutant
C
s
t
p
0
0
A
t
t
m
c
o
m
W
s
a
e
s
t
s
p
c
n
f
(
m
i
o
s
(
c
4
fl
c
c
t
Q
p
b
D
C
c
p
t
t
g
a
e
b
(
t
tni
ca
l
C
ha
ra
ct
er
is
ti
cs
of
P
er
so
ns
C
ar
ry
in
g
A
N
K
R
D
1
or
TT
N
M
ut
at
io
ns
ab
le
1
C
lin
ic
al
C
ha
ra
ct
er
is
ti
cs
of
P
er
so
ns
C
ar
ry
in
g
A
N
K
R
D
1
or
TT
N
M
ut
at
io
ns
ID
M
ut
at
io
n
A
ge
(y
rs
),
S
ex
A
ge
at
O
ns
et
(y
rs
)
C
lin
ic
al
D
ia
gn
os
is
A
ge
at
C
E
(y
rs
)
Fa
m
ily
H
is
to
ry
of
C
M
N
Y
H
A
Fu
nc
ti
on
al
C
la
ss
LV
ED
D
(m
m
)
LV
ES
D
(m
m
)
IV
S
(m
m
)
P
W
(m
m
)
%
FS
%
EF
O
th
er
R
em
ar
ks
ay
o
I
A
N
K
R
D
1
P
5
2
A
4
4
,m
al
e
3
0
H
C
M
3
2
N
o
II
—
—
2
2
—
—
7
0
LV
H
on
EC
G
;p
ro
vo
ca
bl
e
gr
ad
ie
nt
10
0
m
m
H
g,
bu
t
as
ym
pt
om
at
ic
ay
o
II
A
N
K
R
D
1
P
5
2
A
6
5
,m
al
e
4
1
H
C
M
5
4
N
o
III
3
8
1
6
1
4
1
4
—
8
4
M
id
ve
nt
ri
cu
la
r-
ap
ic
al
hy
pe
rt
ro
ph
y
w
ith
m
id
ve
nt
ri
cu
la
r
w
al
l
th
ic
kn
es
s
up
to
3
5
m
m
M
1
2
8
8
II-
2
A
N
K
R
D
1
T1
2
3
M
6
2
,f
em
al
e
4
0
H
C
M
4
0
N
o
I
4
1
2
2
1
3
1
3
4
6
7
8
La
te
ra
lL
VH
(1
5
m
m
),
LA
D
3
7
m
m
,
EC
G
:a
bn
or
m
al
Q
-w
av
e
in
II,
III
,
aV
f,
V 4
–V
6
ay
o
III
A
N
K
R
D
1
I2
8
0
V
8
2
,f
em
al
e
6
1
H
C
M
7
3
N
o
III
5
2
3
0
2
0
1
4
—
7
0
S
ep
ta
la
bl
at
io
n
(r
el
ie
ve
d
ob
st
ru
ct
io
n
7
3
m
m
H
g

2
2
m
m
H
g)
M
8
9
TT
N
R
8
5
0
0
H
5
9
,m
al
e
5
3
H
C
M
5
9
N
o
I
4
2
2
5
2
8
8
4
0
7
9
LV
H
(A
S
H
)
M
1
4
8
0
II-
4
TT
N
R
8
6
0
4
Q
5
2
,m
al
e
4
3
H
C
M
4
3
Ye
s
I
4
1
2
4
1
8
1
0
4
1
8
0
LV
H
(A
S
H
),
at
ri
al
fib
ri
lla
tio
n
EC
G
:
in
ve
rt
ed
T-
w
av
e
in
V 4
–V
6
M
1
4
8
1
III
-1
TT
N
R
8
6
0
4
Q
2
5
,m
al
e
1
6
H
C
M
1
6
Ye
s
I
4
5
2
7
2
2
9
4
0
6
6
LV
H
(A
S
H
),
EC
G
:i
nv
er
te
d
T-
w
av
e
in
V 1
–V
3
cl
in
ic
al
ex
am
in
at
io
n;
EC
G

el
ec
tr
oc
ar
di
og
ra
m
;
EF

ej
ec
tio
n
fr
ac
tio
n;
FS

fr
ac
tio
na
l
sh
or
te
ni
ng
;
H
C
M

hy
pe
rt
ro
ph
ic
ca
rd
io
m
yo
pa
th
y;
ID

id
en
tifi
ca
tio
n;
IV
S

in
tr
av
en
tr
ic
ul
ar
se
pt
al
th
ic
kn
es
s;
LA
D

le
ft
an
te
ri
or
de
sc
en
di
ng
ar
te
ry
;
LV
ED
D

le
ft
ve
nt
ri
cu
la
r
-d
ia
st
ol
ic
di
am
et
er
;L
VE
S
D

le
ft
ve
nt
ri
cu
la
r
en
d-
sy
st
ol
ic
di
am
et
er
;L
VH

le
ft
ve
nt
ri
cu
la
r
hy
pe
rt
ro
ph
y;
N
YH
A

N
ew
Yo
rk
H
ea
rt
A
ss
oc
ia
tio
n;
P
W

po
st
er
io
r
w
al
lt
hi
ck
ne
ss
.
338 Arimura et al. JACC Vol. 54, No. 4, 2009
CARP (ANKRD1) Mutations in HCM July 21, 2009:334–42ARP construct was cotransfected with a MYPN con-
truct. Western blot analysis revealed that binding of mu-
ant CARPs, Pro52Ala, Thr123Met, or Ile280Val to myo-
alladin was significantly increased (3.60  0.67 AU, p 
.001; 1.87  0.47 AU, p  0.01; or 2.48  0.45 AU, p 
.001, respectively) (Figs. 2C and 2D).
ltered localization of CARP caused by the muta-
ions. To further investigate the functional consequence of
he CARP mutations, we examined cellular distribution of the
utant CARP proteins expressed in neonatal rat primary
ardiomyocytes. Cells were transfected with myc-tagged WT
r mutant CARP constructs, coimmunostained for myc (a
arker for CARP) and -actinin (a marker for Z-disc). The
T and mutant myc-CARP proteins were expressed at a
imilar level in the transfected cells as assessed by Western-blot
nalyses, suggesting that the mutations did not affect the
xpression level and stability of CARP proteins (data not
hown). Control cells expressing myc-tag alone showed nega-
ive staining for myc-tag with striated staining pattern of
arcomeric -actinin at the Z-disc (data not shown). In
remature cardiomyocytes containing Z-bodies (Z-disc pre-
ursors), myc-tagged WT CARP was mainly targeted to
ucleus and colocalization of CARP with -actinin, which
ormed patchy dense bodies in the cytoplasm, was observed
Figs. 3A to 3C). No apparent changes in localization of
utant CARP proteins were observed in the nascent and
mmature cardiomyocytes (Figs. 3D to 3L).
In the mature cardiomyocytes where Z-discs were well
rganized, myc-tagged WT CARP was assembled in the
triated pattern at the Z-I bands and colocalized with -actinin
Figs. 4A to 4C). It was found that most (90%) of mature
ardiomyocytes did not contain nuclear CARP (Figs. 4A to
C). On the other hand, higher intensity of CARP-related
uorescence at the Z-I bands and diffused localization in
ytoplasm was observed in most (80%) of the mature
ardiomyocytes expressing myc-tagged mutant CARPs, albeit
hat the Z-disc assembly was not impaired (Figs. 4D to 4L).
uite interestingly, myc-tagged mutant CARP proteins dis-
layed localization within the nuclear and/or at nuclear mem-
rane in 60% of mature cardiomyocytes (Figs. 4D to 4L).
iscussion
ARP encoded by ANKRD1 is a nuclear transcription
ofactor expressing in the embryonic hearts. Its expression
rogressively decreases in adult hearts (4,5) and reappears in
he hypertrophied or failing adult heart (6,22), suggesting
hat CARP may be involved in the regulation of muscle
ene expression. CARP also localizes in cardiac sarcomere
lthough the roles of “sarcomeric CARP” are not fully
lucidated. Several reports have demonstrated that CARP
inds titin/connectin (10), myopalladin (9), and desmin
21) at the Z/I-region of sarcomere. In this study, we found
hat the HCM-associated ANKRD1 mutations increased
he binding of CARP to titin/connectin and myopalladin,and HCM-associated TTN mutations in its reciprocalCl
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July 21, 2009:334–42 CARP (ANKRD1) Mutations in HCMARP N2A-binding domain increased the binding of
itin/connectin to CARP. These observations in associ-
Figure 2 Binding of CARP to TTN and MYPN
Binding of cardiac ankyrin repeat protein (CARP) to titin/connectin (TTN) or myopal
CARPs coprecipitated with GFP-tagged TTN-N2A domain were shown (top panel). E
were confirmed by immunoblotting of whole cell supernatants. Binding pairs were
N2A , or WT TTN-N2A with WT, P52A, T123M, or I280V mutant CARP. Dashes indi
tors, respectively). (B) Densitometric data obtained in the co-IP assay. Data for W
represented as means  SEM (n  6 for each case). *p  0.05 versus WT; **p
with GFP-tagged full-length MYPN was detected by immunoblotting using anti-myc a
tagged CARP (lower panel) were confirmed as in (A). Binding pairs were full-leng
analysis of myc-blotting data in (C). Data were arbitrarily represented as intensit
1.00 AU. Data are expressed as means  SEM (n  9 for each case). **p  0.0tion with HCM suggested that the assembly or binding ff sarcomeric CARP with titin/connectin and/or myo-
alladin would be required for the maintenance of cardiac
MYPN) was analyzed by coimmunoprecipitation (co-IP) assays. (A) Myc-tagged
ions of GFP-tagged TTN- N2A (middle panel) and myc-tagged CARP (lower panel)
e (WT) CARP in combination with WT, I8474T, R8500H, or R8604Q mutant TTN-
o GFP- or myc-tagged proteins (transfected only with pEGFP-C1 or pCMV-Tag3 vec-
with WT TTN-N2A were arbitrarily defined as 1.00 arbitrary unit (AU). Data are
1 versus WT; ***p  0.001 versus WT. (C) Myc-tagged CARP coprecipitated
y (top panel). Expressed amounts of GFP-tagged MYPN (middle panel) and myc-
-MYPN with WT, P52A, T123M, or I280V mutant CARP. (D) Densitometric
d that for WT CARP with full length or N-terminal half WT MYPN were defined as
us WT; ***p  0.001 versus WT.ladin (
xpress
wild-typ
cate n
T CARP
 0.0
ntibod
th WT
ies, an
1 versunction.
w
B
h
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ere detected within the nucleus irrespective of mutations.
Figure 3 Distribution Myc-Tagged CARP in Immature Rat Cardi
Neonatal rat cardiomyocytes transfected with myc-tagged wild-type (WT) (A to C) o
tein (CARP) constructs were fixed 18 h after the transfection, and stained with 4’6
body (B, E, H, K). Merged images (C, F, I, L) are shown. In the immature cardiom
CARPs were preferentially localized to the nucleus, and mutant CARP showed relatecause CARP is an early differentiation marker during ieart development, recruitment of CARP into nuclei may
e important in the embryonic gene expression. Interest-
cytes
nt P52A (D to F), T123M (G to I), or I280V (J to L) cardiac ankyrin repeat pro-
dino-2-phenylindole (DAPI) and anti–-actinin antibody followed by secondary anti-
s showing nascent myofibrils with Z bodies (Z-disc precursors), myc-tagged
w expression in the cytoplasm. Scale bar  10 m.omyo
r muta
-diami
yocyte
ively longly, abnormal intranuclear accumulation of myc-tagged
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July 21, 2009:334–42 CARP (ANKRD1) Mutations in HCMFigure 4 Distribution of Myc-Tagged CARP in Mature Rat Cardiomyocytes
Neonatal rat cardiomyocytes transfected with myc-tagged wild-type (WT) (A to C) or mutant P52A (D to F), T123M (G to I), or I280V (J to L) cardiac ankyrin repeat pro-
tein (CARP) constructs were fixed 48 h after the transfection, and stained with 4’6-diamidino-2-phenylindole (DAPI) and anti–-actinin antibody followed by secondary anti-
body (B, E, H, K). Merged images (C, F, I, L) are shown. In the mature cardiomyocytes showing myofibrils with Z-discs, normal localization of myc-tagged WT CARP at the
Z-discs was observed (A to C). In contrast, myc-tagged mutant CARP proteins showed intense localization at the I-discs (colocalization with -actinin) and diffused local-
ization in the cytoplasm (D to F, G to I, J to L). In addition, myc-tagged mutant CARPs expressed at high levels around the nuclear membrane (white arrows) and/or in
the nucleus (white arrowheads). Scale bar  10 m.
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CARP (ANKRD1) Mutations in HCM July 21, 2009:334–42utant CARP proteins was observed in mature myofibrils.
t is well known that the embryonic and fetal gene program
f cardiac cytoskeletal proteins is initiated during the cardiac
emodeling (22,23). Hence, one could hypothesize that
uclear CARP may cause embryonic/fetal gene expression
n mature myofibrils, and this abnormal gene expression is a
ossible mechanism leading to the pathogenesis of HCM. It
as reported that CARP negatively regulated expression of
ardiac genes including MYL2, TNNC1, and ANP (4,5).
onversely, another report suggested that different expres-
ion level of CARP did not correlate with the altered
xpression of cardiac genes such as MYL2, MYH7, ACTC,
ACTN, TPM1, ACTN2, and DES (24). Thus, the role of
ARP as a regulator of cardiac gene expression remains to
e resolved. During the preparation of this paper, Cinquetti
t al. (25) reported other CARP mutations, rearrangements,
r Thr116Met, in association with the cyanotic congenital
eart anomaly known as total anomalous pulmonary venous
eturn. These mutations were demonstrated to be associated
ith increased expression or stability of CARP. It is not
lear whether the mutations associated with HCM altered
xpression or stability of CARP, although our data sug-
ested that HCM-associated CARP mutations did not alter
he stability. The molecular mechanisms underlying the
ARP-related pathogenesis should be different between
otal anomalous pulmonary venous return and HCM.
onclusions
e identified 3 missense CARP mutations in 1% of
nrelated patients with HCM, which not only increased the
inding of sarcomeric CARP to I-band components but
lso resulted in the mislocalization of CARP to the nucleus.
lthough the molecular mechanisms of HCM due to the
ARP mutations remain to be elucidated, our findings
mply that HCM may be associated with the abnormal
ecruitment of CARP in cardiomyocytes, leading to patho-
ogical hypertrophy.
cknowledgments
he authors thank Drs. Hironori Toshima, Chuichi Kawai,
eishiro Kawamura, Makoto Nagano, Tsuneaki Sugimoto,
atoshi Ogawa, Akira Matsumori, Shigetake Sasayama,
yozo Nagai, and Yoshio Yazaki for their contributions in
linical evaluation and blood sampling from patients with
ardiomyopathy, and Ms. Mieko Yanokura, Maki Emura,
nd Ayaka Nishimura for their technical assistance.
eprint requests and correspondence: Dr. Akinori Kimura,
epartment of Molecular Pathogenesis, Medical Research Insti-
ute, Tokyo Medical and Dental University, 1-5-45 Bunkyo-Ku,
okyo 113-8510, Japan. E-mail: akitis@mri.tmd.ac.jp.
EFERENCES1. Richardson P, McKenna W, Bristow M, et al. Report of the 1995
World Health Organization/International Society and Federation of
K
cCardiology Task Force on the Definition and Classification of
cardiomyopathies. Circulation 1996;93:841–2.
2. Ahmad F, Seidman JG, Seidman CE. The genetic basis for cardiac
remodeling. Annu Rev Genomics Hum Genet 2005;6:185–216.
3. Bos JM, Ommen SR, Ackerman MJ. Genetics of hypertrophic
cardiomyopathy: one, two, or more diseases? Curr Opin Cardiol
2007;22:193–9.
4. Jeyaseelan R, Poizat C, Baker RK, et al. A novel cardiac-restricted
target for doxorubicin. CARP, a nuclear modulator of gene expression
in cardiac progenitor cells and cardiomyocytes. J Biol Chem 1997;272:
22800–8.
5. Zou Y, Evans S, Chen J, Kuo HC, Harvey RP, Chien KR. CARP, a
cardiac ankyrin repeat protein, is downstream in the Nkx2-5 ho-
meobox gene pathway. Development 1997;124:793–804.
6. Zolk O, Frohme M, Maurer A, et al. Cardiac ankyrin repeat protein,
a negative regulator of cardiac gene expression, is augmented in human
heart failure. Biochem Biophys Res Commun 2002;293:1377–82.
7. Ihara Y, Suzuki YJ, Kitta K, Jones LR, Ikeda T. Modulation of gene
expression in transgenic mouse hearts overexpressing calsequestrin.
Cell Calcium 2002;32:21–9.
8. Baudet S. Another activity for the cardiac biologist: CARP fishing.
Cardiovasc Res 2003;59:529–31.
9. Bang ML, Mudry RE, McElhinny AS, et al. Myopalladin, a novel
145-kilodalton sarcomeric protein with multiple roles in Z-disc and
I-band protein assemblies. J Cell Biol 2001;153:413–27.
0. Miller MK, Bang ML, Witt CC, et al. The muscle ankyrin repeat
proteins: CARP, ankrd2/Arpp and DARP as a family of titin filament-
based stress response molecules. J Mol Biol 2003;333:951–64.
1. Granzier HL, Labeit S. The giant protein titin: a major player in
myocardial mechanics, signaling, and disease. Circ Res 2004;94:284–95.
2. LeWinter MM, Wu Y, Labeit S, Granzier H. Cardiac titin: structure,
functions and role in disease. Clin Chim Acta 2007;375:1–9.
3. Itoh-Satoh M, Hayashi T, Nishi H, et al. Titin mutations as the
molecular basis for dilated cardiomyopathy. Biochem Biophys Res
Commun 2002;291:385–93.
4. Gerull B, Gramlich M, Atherton J, et al. Mutations of TTN, encoding
the giant muscle filament titin, cause familial dilated cardiomyopathy.
Nat Genet 2002;30:201–4.
5. Hayashi T, Arimura T, Itoh-Satoh M, et al. Tcap gene mutations in
hypertrophic cardiomyopathy and dilated cardiomyopathy. J Am Coll
Cardiol 2004;44:2192–201.
6. Arimura T, Hayashi T, Terada H, et al. A Cypher/ZASP mutation
associated with dilated cardiomyopathy alters the binding affinity to
protein kinase C. J Biol Chem 2004;279:6746–52.
7. Van Driest SL, Vasile VC, Ommen SR, et al. Myosin binding protein
C mutations and compound heterozygosity in hypertrophic cardiomy-
opathy. J Am Coll Cardiol 2004;44:1903–10.
8. Bos JM, Poley RN, Ny M, et al. Genotype-phenotype relationships
involving hypertrophic cardiomyopathy-associated mutations in titin,
muscle LIM protein, and telethonin. Mol Genet Metab 2006;88:78–85.
9. Arimura T, Matsumoto Y, Okazaki O, et al. Structural analysis of
obscurin gene in hypertrophic cardiomyopathy. Biochem Biophys Res
Commun 2007;362:281–7.
0. Aihara Y, Kurabayashi M, Saito Y, et al. Cardiac ankyrin repeat
protein is a novel marker of cardiac hypertrophy: role of M-CAT
element within the promoter. Hypertension 2000;36:48–53.
1. Witt SH, Labeit D, Granzier H, Labeit S, Witt CC. Dimerization of
the cardiac ankyrin protein CARP: implications for MARP titin-
based signaling. J Muscle Res Cell Motil 2006:1–8.
2. Swynghedauw B. Molecular mechanisms of myocardial remodeling.
Physiol Rev 1999;79:215–62.
3. Swynghedauw B, Baillard C. Biology of hypertensive cardiomyopathy.
Curr Opin Cardiol 2000;15:247–53.
4. Torrado M, Lopez E, Centeno A, Castro-Beiras A, Mikhailov AT.
Left-right asymmetric ventricular expression of CARP in the piglet
heart: regional response to experimental heart failure. Eur J Heart Fail
2004;6:161–72.
5. Cinquetti R, Badi I, Campione M, et al. Transcriptional deregulation
and a missense mutation define ANKRD1 as a candidate gene for total
anomalous pulmonary venous return. Hum Mutat 2008;29:468–74.ey Words: hypertrophic cardiomyopathy y mutation y Z-disc y
ardiac ankyrin repeat protein y titin/connectin.
